Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

CLSA reaffirmed Bharti Airtel as Indias top telecom pick, citing robust growth potential and 5G expansion. Indus Towers, Tata Communications, and others also received mixed ratings, while Vodafone ...

2025 Market Outlook: CLSA anticipates a challenging year for the Nifty in 2025, driven by an uncertain and risky global macro environment coupled with a near-term economic slowdown in India.

CLSA has initiated coverage on Hyundai Motor India with an 'Outperform' rating and a target price of Rs 2,155, citing strong ...

Vikash Kumar Jain, India Strategist and Head of Research at CLSA, predicts 2025 will be a year of consolidation for Indian markets. He noted that the consolidation trend, which began in October, could ...

Finance companies' performance in the first half of 2025 is expected to be impacted by high credit costs due to unsecured credit. But it is seen normalising in the second half on underwriting ...

Shares of most staples companies in India, from HUL, to Nestle India to ITC, or even Avenue Supermarts, have corrected between 20% to 30% from their peak so far.

The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...